Colonia Care Pharmacy Recalls C-Methylcobalamin Injections Due to Sterility Concerns
Colonia Care Pharmacy is recalling 191 syringes of C-Methylcobalamin 25mg/mL injection because the product's sterility cannot be guaranteed.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class II. According to the rubric, an FDA Class II recall involving a structural defect or significant risk (such as lack of sterility in an injectable drug) is categorized as Severe.
Plain-English summary
Colonia Care Pharmacy is recalling 191 syringes of C-Methylcobalamin 25mg/mL Injection PFS. The product is packaged in 0.3 mL, 0.5 mL, 1 mL, and 3 mL syringes and is available by prescription only. The recall was initiated because the sterility of the product cannot be guaranteed.
The affected lots are 020719A with a beyond-use date of 08/06/19, and 051619E with a beyond-use date of 11/12/19. These products were distributed via patient-specific prescriptions in New Jersey.
Patients who have received this medication should contact their healthcare provider for further instructions. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- C-METHYLCOBALAMIN 25MG/ML INJECTION PFS, packaged in 0.3 mL, 0.5 mL, 1 mL, and 3 mL syringes, Rx only, Colonia Care Pharmacy, 515 Inman Ave., Suite A, Colonia, N.J. 07067
- Manufacturer
- Colonia Care Pharmacy
- Category
- Drug — Injectable
- Hazard
- Affected units
- 191
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 020719A
- BUD 08/06/19
- 051619E
- BUD 11/12/19
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 32 recalled by Colonia Care Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 32 products in this recall →Related recalls
Same manufacturer · Colonia Care Pharmacy
See all →- SevereColonia Care Pharmacy Recalls C-Papav/Phentol/PGE1 Vials Due to Sterility Concerns
FDA (Drugs) · 2019-10-09
- SevereColonia Care Pharmacy Recalls Gentamicin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-10-09
- SevereColonia Care Pharmacy Recalls C-Papav/Phentol/PGE1 Vials for Sterility Concerns
FDA (Drugs) · 2019-10-09
- SevereColonia Care Pharmacy Recalls Verapamil Injection Due to Sterility Concerns
FDA (Drugs) · 2019-10-09
- SevereColonia Care Pharmacy Recalls Sterility-Compromised C-Papav/Phentol/PGE1 Vials
FDA (Drugs) · 2019-10-09
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereColonia Care Pharmacy Recalls Injectable Drug Products Due to Sterility Concerns
FDA (Drugs) · 2016-12-28
- SevereMethylcobalamin Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2022-03-23
- SeverePromise Pharmacy Recalls Methylcobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2019-02-20
- SeverePromise Pharmacy Recalls Methylcobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2019-02-20
- SevereEssential Wellness Recalls Methylcobalamin Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereMoses Lake Pharmacy Recalls Methylcobalamin Injectable Solution Due to Sterility Concerns
FDA (Drugs) · 2015-11-04